Effect of olprinone, a phosphodiesterase III inhibitor, on arterial wall distensibility: Differentiation between aorta and common carotid artery

Heart and Vessels

Volumn 14, Issue 5, 1999, Pages 224-231

  Seki, Makoto ^a   Mizushige, Katsufumi ^a   Ueda, Takashi ^a   Kitadai, Masaya ^a   Matsuo, Hirohide ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Echocardiography; Ol prinone; Phosphodiesterase III inhibitor; Stiffness parameter ; Vascular elasticity

Indexed keywords

LOPRINONE; PHOSPHODIESTERASE INHIBITOR;

ABDOMINAL AORTA; ADULT; AGED; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; ASCENDING AORTA; BLOOD FLOW VELOCITY; COMMON CAROTID ARTERY; DOPPLER ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; M MODE ECHOCARDIOGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR RESISTANCE;

EID: 0033504795     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01747851     Document Type: Article

References (5)

1. Takaoka H, Takeuchi M, Okada M, Hayashi Y, Mori M, Hata K, Yokoyama M (1993) Comparsion of the effects on arterial-ventricular coupling between phosphodiesterase inhibitor and dobutamine in the diseased human heart. J Am Coll Cardiol 22:598-606
2. Murakami R, Sano K, Murakami Y, Shimada T, Morioka S (1995) Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochroride), on cardiac func-tion: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship. Int J Cardiol 51:57-63
3. Monrad ES, Baim DS, Smith HS, Lanoue AS, Braunwald E, Grossman W (1985) Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 71:972-979
4. Silver PJ (1989) Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase. Am J Cardiol 63(suppl):2-8
5. Drummond GI, Severson DL (1979) Cyclic nucleotides and cardiac function. Circ Res 44:145-153